Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease

Abstract

SummaryBackground : Small bowel bacterial overgrowth is common in Crohn's disease but its treatment is not clearly defined. Metronidazole and ciprofloxacin are effective antibiotics in active Crohn's disease.Aim : To investigate the efficacy of metronidazole and ciprofloxacin in the treatment of bacterial overgrowth in patients with Crohn's disease.Patients and methods : We performed the lactulose breath test in 145 consecutive patients affected by Crohn's disease. Patients positive to the lactulose breath test underwent a glucose breath test to confirm the overgrowth. These patients were randomized in two treatment groups: metronidazole 250 mg t.d.s. (Group A) and ciprofloxacin 500 mg b.d. (Group B), both orally for 10 days. The glucose breath test was repeated at the end of treatment. The clinical outcome after therapy was also recorded.Results : Bacterial overgrowth was present in 29 patients (20%). Breath test normalization occurred in 13 out of 15 patients treated by metronidazole and in all 14 patients treated by ciprofloxacin (P = ns). In both groups antibiotic treatment induced an improvement of intestinal symptoms: bloating (Group A 85% and Group B 83%), stool softness (44% and 50%), and abdominal pain (50% and 43%).Conclusions : Small bowel bacterial overgrowth is a frequent condition in Crohn's disease which can be effectively treated by metronidazole or ciprofloxacin.

Small Bowel Bacterial Overgrowth in Symptomatic Older People: Can It Be Diagnosed Earlier?

“…In concurrence with our fi ndings, quinolones, metronidazole and amoxicillin-clavulanic acid have reported effi cacy [29,30] , whereas tetracyclines have lower effi cacy [31] . Further work is needed to examine the effi cacy of different antibiotic regimes.…”

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

“…On the other hand, the difficulty in identifying the specific bacterial population and the affected part of the digestive tract by SIBO prevents the possibility of using targeted antibiotics; the recommendation is to use a broad-spectrum antibiotic therapy, capable of eradicating aerobes and anaerobes, preferably with a topical rather than a general action. Valuable alternatives to Rifaximin that have been proven to be effective in the treatment of SIBO are norfloxacin and amoxicillinclavulanic acid [21] , levofloxacin and/or metronidazole [22] , gentamycin [23] , trimethoprim/sulfamerazine and polymyxin [24] , and chlortetracycline [18] .…”

Anti-microbial antibodies in celiac disease: Trick or treat?

“…The presence of serological response might be the reflection of the sustained exposure to the constituent of the gut microflora due to the enhanced bacterial translocation. The known predisposing factors for bacterial translocation, such as bacterial overgrowth in the small bowel (secondary to intestinal dysmotility) [41][42][43] , the damage to the integrity of the gut Papp M et al . Antibodies in celiac disease mucosa (secondary to alterations of the local intestinal microvasculature) [44,45] , which results in reduced oxygen delivery and an increased formation in oxygen radicals [46] as well as the upregulation of the proinflammatory cytokines, such as tumor necrosis factor α, interleukin-17 or interferon gamma in active lesions [47] , and the defective mucosal immunological defense [21,48] are all typical features in both clinical conditions.…”